Description
BNP A1C HCG REAGENTS
First action · last action
2017-10-11 · 2019-06-12
Transactions
2
First transaction's obligation
$197,805
Base + all options value (sum of deltas)
$194,644
Extent competed
FULL AND OPEN COMPETITION
Other than full & open authority
—
Set-aside
—
Offers received
1
SDVOSB flag on record
No
Parent IDV
V797P5076B
NAICS
325413 · IN-VITRO DIAGNOSTIC SUBSTANCE MANUFACTURING
Modification chain · 2 transactions
Each row is one published transaction. This action is the obligation recorded on that transaction — a change amount, as USAspending publishes it. Running total is computed by Glassbox VA as the cumulative sum of those amounts up to and including the row, so the last running total equals the award's net obligations shown above. The cumulative-total columns in the source files are not used: they are not frozen per modification.
- Base2017-10-11+$197,805= $197,805
- Mod P000012019-06-12-$3,161= $194,644
| Transaction | Action date | This action (delta) | Running total | Description on this transaction |
|---|---|---|---|---|
| Base | 2017-10-11 | +$197,805 | $197,805 | BNP A1C HCG REAGENTS |
| Mod P00001· OTHER ADMINISTRATIVE ACTION | 2019-06-12 | −$3,161 | $194,644 | BNP A1C HCG REAGENTS |
Related awards · 11
Awards are related by an explicit link in the data, stated for each group below — never by text similarity. Values are net obligations.
Other VA awards to the same recipient (UEI P782RNU1NNK3)
| Award | Office · PSC / listing | Net obligations | FY |
|---|---|---|---|
| 36C25026P0699 | 250-NETWORK CONTRACT OFFICE 10 (36C250) · 6550 · IN VITRO DIAGNOSTIC SUBSTANCES, REAGENTS, TEST KITS AND SETS | $82,304 | FY2026 |
| 36C24426N0511 | 244-NETWORK CONTRACT OFFICE 4 (36C244) · 6515 · MEDICAL AND SURGICAL INSTRUMENTS, EQUIPMENT, AND SUPPLIES | $48,635 | FY2026 |
| 36C25526N0126 | 255-NETWORK CONTRACT OFFICE 15 (36C255) · 6550 · IN VITRO DIAGNOSTIC SUBSTANCES, REAGENTS, TEST KITS AND SETS | $54,108 | FY2026 |
| 36C24126N0170 | 241-NETWORK CONTRACT OFFICE 01 (36C241) · 6550 · IN VITRO DIAGNOSTIC SUBSTANCES, REAGENTS, TEST KITS AND SETS | $123,000 | FY2026 |
| 36C24226N0185 | 242-NETWORK CONTRACT OFFICE 02 (36C242) · 6550 · IN VITRO DIAGNOSTIC SUBSTANCES, REAGENTS, TEST KITS AND SETS | $0 | FY2026 |
| 36C24425N0741 | 244-NETWORK CONTRACT OFFICE 4 (36C244) · 6515 · MEDICAL AND SURGICAL INSTRUMENTS, EQUIPMENT, AND SUPPLIES | $48,635 | FY2025 |
Other recipients under 6550 from 257-NETWORK CONTRACT OFFICE 17 (36C257) (most recent first)
| Award | Recipient | Office | Net obligations | FY |
|---|---|---|---|---|
| 36C25726N0474 | ROCHE DIAGNOSTICS CORPORATION | 257-NETWORK CONTRACT OFFICE 17 (36C257) | $21,384 | FY2026 |
| 36C25726N0497 | POLYMEDCO LLC | 257-NETWORK CONTRACT OFFICE 17 (36C257) | $30,770 | FY2026 |
| 36C25726N0477 | BECTON, DICKINSON AND COMPANY | 257-NETWORK CONTRACT OFFICE 17 (36C257) | $337,374 | FY2026 |
| 36C25726D0094 | BECTON, DICKINSON AND COMPANY | 257-NETWORK CONTRACT OFFICE 17 (36C257) | $0 | FY2026 |
| 36C25726N0476 | BECKMAN COULTER, INC | 257-NETWORK CONTRACT OFFICE 17 (36C257) | $1,450,556 | FY2026 |
Cite as: Glassbox VA record view · VA contract (USAspending / FPDS) · CONT_AWD_36C25718N0027_3600_V797P5076B_3600 · retrieved 2026-09-26.